ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Boc-N'-(2-chlorobenzyloxycarbonyl)-L-lysine
C19H27ClN2O6
414.9 g/mol
Pharmaceutical Intermediate

Boc-Lys(2-Cl-Z)-OH

CAS54613-99-9
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Boc-Lys(2-Cl-Z)-OH is a protected lysine derivative used as a pharmaceutical intermediate in peptide synthesis. Its structure includes a tert-butoxycarbonyl (Boc) protecting group on the alpha-amino group and a 2-chlorobenzyloxycarbonyl (2-Cl-Z) protecting group on the lysine side chain, enabling selective deprotection during solid-phase peptide assembly.

Pharmaceutical intermediate for peptide synthesisBuilding block in solid-phase peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Boc-Lys(2-Cl-Z)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.94

N-Boc-N'-(2-chloro-Cbz)-L-ornithine

CAS118554-00-0

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.76

N-Boc-N'-Cbz-L-lysine

CAS2389-45-9

pharmaceutical intermediate

ReferenceSame Category

3-Acetylneamine

CAS54617-39-9

pharmaceutical intermediate

ReferenceSame Category

N-(4,5-Dichloro-2-nitrophenyl)acetamide

CAS5462-30-6

pharmaceutical intermediate

ReferenceSame Category

L-threo-Ritalinic Acid

CAS54631-24-2

pharmaceutical intermediate

ReferenceSame Category

Neomycin EP Impurity G

CAS54631-94-6

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-6-[(2-chlorophenyl)methoxycarbonylamino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid

InChIKey

ATUMDPHEFWGCJF-HNNXBMFYSA-N

SMILES

CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCC1=CC=CC=C1Cl)C(=O)O

Synonyms (13)
  • Boc-L-Lys(2-Cl-Z)-OH
  • Boc-Lys(2-Cl-Z)-OH
  • Boc-Lys(2-chloro-Z)-OH
  • Boc-Lys(Cl-Z)-OH

Sourcing Boc-Lys(2-Cl-Z)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→